🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in the EU / 2025-521384-12-00
Completed Phase I

A research study to compare blood levels of cagrilintide after multiple doses of different versions of cagrilintide in adults with overweight or obesity

2025-521384-12-00 · tracked via the Priya Life Science EU tracker
Sponsor
Novo Nordisk A/S
Sponsor type
Pharmaceutical company
Therapeutic area
Nutritional and Metabolic Diseases
Decision date
21/04/2026
Enrollment target
234
Sites
Germany

Condition studied

obesity

Eligibility

Age group
18-64 years
Sex
Female, Male
Official registry record

This page summarises publicly available CTIS data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View 2025-521384-12-00 on CTIS ↗ ← All trials in the EU